Tectonic Therapeutic | AVRO - Pre Tax Profit

Stock Price
32.00
Daily Change
-0.15 -0.47%
Monthly
49.74%
Yearly
44.27%
Q1 Forecast
32.30

Tectonic Therapeutic reported $-18.97M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alnylam Pharmaceuticals USD 161.14M 77.83M Dec/2025
Celltrion KRW 14.6B 180.89B Jun/2025
Cspc Pharmaceutical CNY 1.21B 110.04M Sep/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Divis Laboratories Ltd INR 8.54B 580M Dec/2025
Gilead Sciences USD 3.64B 1.21B Sep/2025
Ionis Pharmaceuticals USD -228M 99M Dec/2025
Kangmei Pharma CNY 2.07M 13.77M Sep/2025
Karyopharm Therapeutics USD -30.89M 1.16M Dec/2024
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
MacroGenics USD -14.93M 31.75M Dec/2025
Medical Developments International AUD -149K 466K Jun/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Organigram Holdings CAD -41.72M 25.52M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Pharma Mar EUR 40.2M 44.28M Dec/2025
Qiagen NV USD 134.73M 7.91M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Sanofi EUR -1.16B 5.5B Dec/2025
Sarepta Therapeutics USD -407.67M 213.63M Dec/2025
Sartorius EUR 85M 14.1M Sep/2025
Takeda JPY 133.86B 105.69B Dec/2025
Tilray USD -1.39B 600.71M Mar/2025
Zz Pientze Pharmaceu CNY 523.11M 659.54M Jun/2025